Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
OMICS ; 23(8): 371-379, 2019 08.
Article in English | MEDLINE | ID: mdl-31259670

ABSTRACT

In current biomedicine, omics technologies drive systems-oriented modes of research to achieve a more holistic and personalized view of health and disease. This shift in scientific approach co-occurs with an era of biocapitalism characterized by markets for biomaterial (e.g., DNA, cells, and tissues) as exploitable resources, high-throughput technologies as tools, and "Big Data" as currency. Prediagnostics and genomics-based analyses successfully entered the public domain more or less unfiltered, offering numerous business opportunities envisioning individuals to contribute to the health sector by providing biomaterial and data as well as by using technology, thus becoming participants and informed coproducers of health. Exploring strengths and weaknesses, as well as opportunities and threats by S.W.O.T. analysis, we highlight some chances, pitfalls, and biases of this sector from a bioscience ethics stance. We conclude that the shift from diagnostic to predictive interpretation of data that comes along with integrative biology seems to escape the general and sometimes the experts' awareness. Moreover, rapid translation into products for the global health market is based on marketable views on health and disease that in turn affect basic research through, for example, funding policies and the research questions being asked. Along with this, biological reductionism is revived fuelling simplified understandings of the genotype phenotype relationship in terms of biology and the human dimension in a broader sense, as well as visions of achieving human perfection through novel biotechnologies.


Subject(s)
Big Data , Computational Biology , Systems Biology , Biomedical Research , Computational Biology/ethics , Computational Biology/methods , Computer Security , Confidentiality , Genomics/methods , Humans , Precision Medicine/methods , Systems Biology/ethics , Systems Biology/methods
3.
Adv Biochem Eng Biotechnol ; 162: 301-315, 2018.
Article in English | MEDLINE | ID: mdl-28567486

ABSTRACT

The basic chemical constitution of all living organisms in the context of carbon-based chemistry consists of a limited number of small molecules and polymers. Until the twenty-first century, biology was mainly an analytical science and has now reached a point where it merges with engineering science, paving the way for synthetic biology. One of the objectives of synthetic biology is to try to change the chemical compositions of living cells, that is, to create an artificial biological diversity, which in turn fosters a new sub-field of synthetic biology, xenobiology. In particular, the genetic code in living systems is based on highly standardized chemistry composed of the same "letters" or nucleotides as informational polymers (DNA, RNA) and the 20 amino acids which serve as basic building blocks for proteins. The universality of the genetic code enables not only vertical gene transfer within the same species but also horizontal gene transfer across biological taxa, which require a high degree of standardization and interconnectivity. Although some minor alterations of the standard genetic code are found in nature (e.g., proteins containing non-conical amino acids exist in nature, and some organisms use alternated coding systems), all structurally deep chemistry changes within living systems are generally lethal, making the creation of artificial biological system an extremely difficult challenge.In this context, one of the great challenges for bioscience is the development of a strategy for expanding the standard basic chemical repertoire of living cells. Attempts to alter the meaning of the genetic information stored in DNA as an informational polymer by changing the chemistry of the polymer (i.e., xeno-nucleic acids) or by changes in the genetic code have already yielded successful results. In the future this should enable the partial or full redirection of the biological information flow to generate "new" version(s) of the genetic code derived from the "old" biological world.In addition to the scientific challenges, the attempt to increase biochemical diversity also raises important ethical and philosophical issues. Although promotors of this branch of synthetic biology highlight the many potential applications to come (e.g., novel tools for diagnostics and fighting infection diseases), such developments could also bring risks affecting social, political, and other structures of nearly all societies.


Subject(s)
Bioethical Issues , Genetic Engineering/ethics , Organisms, Genetically Modified , Systems Biology/ethics
4.
BMC Health Serv Res ; 17(1): 761, 2017 Nov 21.
Article in English | MEDLINE | ID: mdl-29162092

ABSTRACT

BACKGROUND: Systems medicine has become a key word in biomedical research. Although it is often referred to as P4-(predictive, preventive, personalized and participatory)-medicine, it still lacks a clear definition and is open to interpretation. This conceptual lack of clarity complicates the scientific and public discourse on chances, risks and limits of Systems Medicine and may lead to unfounded hopes. Against this background, our goal was to develop a sufficiently precise and widely acceptable definition of Systems Medicine. METHODS: In a first step, PubMed was searched using the keyword "systems medicine". A data extraction tabloid was developed putting forward a means/ends-division. Full-texts of articles containing Systems Medicine in title or abstract were screened for definitions. Definitions were extracted; their semantic elements were assigned as either means or ends. To reduce complexity of the resulting list, summary categories were developed inductively. In a second step, we applied six criteria for adequate definitions (necessity, non-circularity, non-redundancy, consistency, non-vagueness, and coherence) to these categories to derive a so-called précising definition of Systems Medicine. RESULTS: We identified 185 articles containing the term Systems Medicine in title or abstract. 67 contained at least one definition of Systems Medicine. In 98 definitions, we found 114 means and 132 ends. From these we derived the précising definition: Systems Medicine is an approach seeking to improve medical research (i.e. the understanding of complex processes occurring in diseases, pathologies and health states as well as innovative approaches to drug discovery) and health care (i.e. prevention, prediction, diagnosis and treatment) through stratification by means of Systems Biology (i.e. data integration, modeling, experimentation and bioinformatics). Our study also revealed the visionary character of Systems Medicine. CONCLUSIONS: Our insights, on the one hand, allow for a realistic identification of actual ethical as well as legal issues arising in the context of Systems Medicine and, in consequence, for a realistic debate of questions concerning its matter and (future) handling. On the other hand, they help avoiding unfounded hopes and unrealistic expectations. This especially holds for goals like improving patient participation which are intensely debated in the context of Systems Medicine, however not implied in the concept.


Subject(s)
Biomedical Research/methods , Systems Analysis , Systems Biology , Delivery of Health Care , Humans , Research Design , Systems Biology/ethics
5.
Dimens Crit Care Nurs ; 30(1): 1-7, 2011.
Article in English | MEDLINE | ID: mdl-21135603

ABSTRACT

Systems biology applies advances in technology and new fields of study including genomics, transcriptomics, proteomics, and metabolomics to the development of new treatments and approaches of care for the critically ill and injured patient. An understanding of systems biology enhances a nurse's ability to implement evidence-based practice and to educate patients and families on novel testing and therapies. Systems biology is an integrated and holistic view of humans in relationship with the environment. Biomarkers are used to measure the presence and severity of disease and are rapidly expanding in systems biology endeavors. A systems biology approach using predictive, preventive, and participatory involvement is being utilized in a plethora of conditions of critical illness and injury including sepsis, cancer, pulmonary disease, and traumatic injuries.


Subject(s)
Critical Care/organization & administration , Specialties, Nursing/organization & administration , Systems Biology/organization & administration , Critical Care/ethics , Evidence-Based Practice , Forecasting , Gene Expression Profiling , Genomics , Holistic Health , Humans , Metabolomics , Models, Nursing , Nurse's Role , Nursing Research , Patient Education as Topic , Patient Participation , Precision Medicine , Primary Prevention , Proteomics , Specialties, Nursing/ethics , Systems Biology/ethics
6.
Int J Mol Sci ; 10(4): 1658-69, 2009 Apr 17.
Article in English | MEDLINE | ID: mdl-19468331

ABSTRACT

In this article we continue our exploration of the historical roots of systems biology by considering the work of William Harvey. Central arguments in his work on the movement of the heart and the circulation of the blood can be shown to presage the concepts and methods of integrative systems biology. These include: (a) the analysis of the level of biological organization at which a function (e.g. cardiac rhythm) can be said to occur; (b) the use of quantitative mathematical modelling to generate testable hypotheses and deduce a fundamental physiological principle (the circulation of the blood) and (c) the iterative submission of his predictions to an experimental test. This article is the result of a tri-lingual study: as Harvey's masterpiece was published in Latin in 1628, we have checked the original edition and compared it with and between the English and French translations, some of which are given as notes to inform the reader of differences in interpretation.


Subject(s)
Heart/physiology , Systems Biology/history , Animals , Blood Circulation/physiology , History, 17th Century , Models, Theoretical , Systems Biology/ethics
7.
Am J Bioeth ; 7(4): 67-78, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17455006

ABSTRACT

Systems biology is the rapidly growing and heavily funded successor science to genomics. Its mission is to integrate extensive bodies of molecular data into a detailed mathematical understanding of all life processes, with an ultimate view to their prediction and control. Despite its high profile and widespread practice, there has so far been almost no bioethical attention paid to systems biology and its potential social consequences. We outline some of systems biology's most important socioethical issues by contrasting the concept of systems as dynamic processes against the common static interpretation of genomes. New issues arise around systems biology's capacities for in silico testing, changing cultural understandings of life, synthetic biology, and commercialization. We advocate an interdisciplinary and interactive approach that integrates social and philosophical analysis and engages closely with the science. Overall, we argue that systems biology socioethics could stimulate new ways of thinking about socioethical studies of life sciences.


Subject(s)
Bioethical Issues , Systems Biology/ethics , Genomics/ethics , Humans
9.
Am J Bioeth ; 7(4): 80-2; discussion W7-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17455008
10.
Am J Bioeth ; 7(4): 83-5; discussion W7-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17455009
11.
Am J Bioeth ; 7(4): 85-6; discussion W7-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17455010
12.
Am J Bioeth ; 7(4): 86-7; discussion W7-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17455011
14.
J Biolaw Bus ; 8(2): 19-29, 2005.
Article in English | MEDLINE | ID: mdl-16538811

ABSTRACT

The emerging field of synthetic biology is broadly defined as the area of intersection of biology and engineering that focuses on the modification or creation of novel biological systems that do not have a counterpart in nature. Potential applications of this technology range from creating systems for environmental cleanup tasks, for medical diagnosis and treatment, to economical generation of hydrogen fuel. This technology is in tis nascent state and there are a number of concerns surrounding its potential applications and the nature of research being performed. With the potential to create hitherto unknown "living organisms", it raises a number of challenges along different dimensions. This article reviews the current state of the technology and analyzes synthetic biology using different lenses: patentability, ethics, and regulation. It proposes a classification system for the products of synthetic biology and provides recommendations in each of the above areas (patentability, ethics, and regulation) in the context of this classification system. These recommendations include an improved framework for patentability testing, ethical principles to guide work in this area, a controlled approval process, and reference frameworks for regulation.


Subject(s)
Biotechnology/ethics , Biotechnology/trends , Genetic Engineering/ethics , Genetic Engineering/trends , Genetic Research/ethics , Life , Patents as Topic , Systems Biology/ethics , Systems Biology/trends , Bacteria/genetics , Biotechnology/legislation & jurisprudence , Biotechnology/methods , Ethical Analysis , Genes, Synthetic , Genetic Engineering/legislation & jurisprudence , Genetic Engineering/methods , Genetic Research/legislation & jurisprudence , Guidelines as Topic , Patents as Topic/ethics , Patents as Topic/legislation & jurisprudence , Risk Assessment , Systems Biology/legislation & jurisprudence , Systems Biology/methods , Viruses/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...